Agent |
Drug |
Effect on gut microbiota |
Effect on renal outcome |
Reference |
||
Phylum level |
Family level |
Genus/species level |
||||
GLP-1 receptor agonists |
Exenatide |
Unknown |
Unknown |
Unknown |
Reduce albuminuria and pathological renal injury |
121,122 |
Liraglutide |
Bacteroides↑, Verrucomicrobia↑, Proteobacteria↓, Actinobacteria↓ |
Rikenellaceae↑, S24-7↑, Erysipelotrichaceae↑, Lachnospiraceae↓, Peptostreptococcacea↓ |
Akkermansia↑, Romboutsia↑, Anaerotruncus↓, Klebsiella↓, Lachnospiraceae_UCG-001↓, Lachnospiraceae_NK4A136_group↓, Ruminiclostridium↓, Desulfovibrio ↓ |
Reduce the incidence of nephropathy and macroalbuminuria |
125,127,129,130 |
|
Dulaglutide |
Bacteroides↑, Firmicutes↓ |
Unknown |
Aerococcus↑, Akkermansia↑, Bacteroides↑, Barnesiella↑, Ruminococcus↑, Oscillibacter↑, Coprobacillus↓ |
Lower the incidence in new-onset large albuminuria and sustained decline of eGFR |
131,133 |
|
Lixisenatide |
Unknown |
Unknown |
Unknown |
Improve UACR |
134,135 |
|
DPP-4 inhibitors |
Linagliptin |
Bacteroides↑, Actinobacteria↓, Proteobacteria↓ |
Unknown |
Unknown |
Reduce proteinuria and improve renal injury |
140,142,143 |
Alogliptin |
Unknown |
Unknown |
Unknown |
Improve UACR and maintain eGFR |
144 |
|
Saxagliptin |
Firmicutes↑, Bacteroides ↓ |
Erysipelotrichaceae↑, Bacteroidaceae ↓ |
Lactobacillus↑, Allobaculum↑, Turicibacter↑, Prevotella ↓ |
Improve UACR |
147,148 |
|
Sitagliptin |
Bacteroides↑, Proteobacteria↑, Actinobacteria↑, Firmicutes↓, Tenericutes↓ |
Ruminococcaceae↑ |
Roseburia↑, Bifidobacterium↑, Blautia ↓ |
Reduce urinary albumin levels |
150,151 |
|
SGLT-2 intibitors |
Canagliflozin |
Actinobacteria↓, TM-7↓ |
Unknown |
Alistipes↑, Alloprevotella↑, Olsenella↑, Oscillospira↓, Bifidobacterium↓, Helicobacter↓, Mucispirillum↓ |
Reduce plasma uremic toxins and lower UACR |
155,157,158 |
Dapagliflozin |
Firmicutes↑, Proteobacteria,↑ Bacteroides ↓, Actinobacteria↓ |
Desulfovibrionaceae↑, Lactobacillaceae ↓ |
Oscillospira↓, Mucispirillum↓, Barnesiella↓ |
Prevent progression of kidney disease |
160−163 |
|
Empagliflozin |
Bacteroides↑, Firmicutes↓ |
Unknown |
Bacteroides↑, Bifidobacterium↑, Parabacteroides↑ |
Reduce the risk of nephropathy, proteinuria and serum creatinine |
133,164,165 |
|
Ertugliflozin |
Unknown |
Unknown |
Unknown |
Reduce the risk of renal composite endpoint and preserve eGFR and UACR |
167,168 |